首页> 外国专利> Glucagon Analogue Compound comprising substitutions of amino acid residues in positions 3 and / or 4 which has activity in native glucagon and Glucagon Receptor and / or the receiverGlp-1, Pharmaceutical composition comprising the compound; the use of compound to prevent Weight gain or to promote weight loss in a subject in need.

Glucagon Analogue Compound comprising substitutions of amino acid residues in positions 3 and / or 4 which has activity in native glucagon and Glucagon Receptor and / or the receiverGlp-1, Pharmaceutical composition comprising the compound; the use of compound to prevent Weight gain or to promote weight loss in a subject in need.

机译:包含在天然胰高血糖素和胰高血糖素受体和/或受体Glp-1中具有活性的位置3和/或4的氨基酸残基的取代的胰高血糖素类似物化合物,包含该化合物的药物组合物;在有需要的受试者中使用化合物预防体重增加或促进体重减轻。

摘要

The invention provides materials and methods for promoting weight loss or preventing weight gain and for treating diabetes and associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptide compounds effective in such methods. The compounds may mediate their effect by having, for example, increased selectivity for the GLP-1 receptor compared to human glucagon.
机译:本发明提供了用于促进体重减轻或防止体重增加以及用于治疗糖尿病和相关代谢紊乱的材料和方法。特别地,本发明提供了在这种方法中有效的新型胰高血糖素类似物肽化合物。与人胰高血糖素相比,所述化合物可通过例如增加对GLP-1受体的选择性来介导其作用。

著录项

  • 公开/公告号CL2012003641A1

    专利类型

  • 公开/公告日2013-09-06

    原文格式PDF

  • 申请/专利权人 ZEALAND PHARMA A/S;

    申请/专利号CL20120003641

  • 发明设计人 RIBER DITTE;MEIER EDDI;

    申请日2012-12-21

  • 分类号A61K38/26;A61P5/48;C07K14/605;

  • 国家 CL

  • 入库时间 2022-08-21 16:42:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号